Authors:
Conley, W
Dean, K
Miller, D
Rich, G
Graffenberg, V
Patel, S
Lin, SH
Jamieson, A
Hung, R
Yamada, S
Pinnow, M
MacDonald, S
Chambers, C
Osborne, B
Patterson, K
Somervell, M
Trinque, B
Tran, HV
Cho, S
Chiba, T
Byers, J
Tomas, B
Shafer, G
DesMarteau, D
Klopp, J
Frechet, J
Sanders, D
Grubbs, R
Ober, C
Korner, H
Willson, CG
Citation: W. Conley et al., Developments in materials for 157nm photoresists, SOL ST TECH, 44(10), 2001, pp. 63
Authors:
Dutta, AS
Gormley, JJ
Coath, M
Hassall, L
Hayward, CF
Gellert, PR
Kittlety, RS
Alcock, PJ
Ferguson, R
Halterman, T
Jamieson, A
Moors, JA
Moores, JM
Rees, A
Wood, LJ
Reilly, CF
Haworth, D
Citation: As. Dutta et al., Potent cyclic peptide inhibitors of VLA-4 (alpha(4)beta(1) integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation, J PEPT SCI, 6(8), 2000, pp. 398-412
Authors:
Dutta, AS
Crowther, M
Gormley, JJ
Hassall, L
Hayward, CF
Gellert, PR
Kittlety, RS
Alcock, PJ
Jamieson, A
Moores, JM
Rees, A
Wood, LJ
Reilly, CF
Haworth, D
Citation: As. Dutta et al., Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha(4)beta(1) integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide, J PEPT SCI, 6(7), 2000, pp. 321-341
Authors:
Brodsky, C
Byers, J
Conley, W
Hung, R
Yamada, S
Patterson, K
Somervell, M
Trinque, B
Tran, HV
Cho, S
Chiba, T
Lin, SH
Jamieson, A
Johnson, H
Vander Heyden, T
Willson, CG
Citation: C. Brodsky et al., 157 nm resist materials: Progress report, J VAC SCI B, 18(6), 2000, pp. 3396-3401
Authors:
Yeung, PKF
Jamieson, A
Smith, GJ
Fice, D
Pollak, PT
Citation: Pkf. Yeung et al., Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection, INT J PHARM, 204(1-2), 2000, pp. 17-22
Authors:
Lindbladh, C
Smith, P
Jackson, L
Begishvilli, B
Jamieson, A
Holgate, ST
Citation: C. Lindbladh et al., A comparison of the bronchodilator effect of salbutamol inhaled via Turbuhaler (R) as two consecutive doses or as two divided doses at different timeintervals, INT J PHARM, 190(1), 1999, pp. 57-62
Authors:
Jamieson, A
Wallace, AM
Andrew, R
Nunez, BS
Walker, BR
Fraser, R
White, PC
Connell, JMC
Citation: A. Jamieson et al., Apparent cortisone reductase deficiency: A functional defect in 11 beta-hydroxysteroid dehydrogenase type 1, J CLIN END, 84(10), 1999, pp. 3570-3574
Authors:
Haworth, D
Rees, A
Alcock, PJ
Wood, LJ
Dutta, AS
Gormley, JJ
Jones, HB
Jamieson, A
Reilly, CF
Citation: D. Haworth et al., Anti-inflammatory activity of c(ILDV-NH(CH2)(5)CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesion, BR J PHARM, 126(8), 1999, pp. 1751-1760
Authors:
MacConnachie, AA
Kelly, KF
McNamara, A
Loughlin, S
Gates, LJ
Inglis, GC
Jamieson, A
Connell, JMC
Haites, NE
Citation: Aa. Macconnachie et al., Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism, J CLIN END, 83(12), 1998, pp. 4328-4331